Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Common Stock	Treasury Stock Shares	Additional Paid-In Capital	Subscription Receivables	Accumulated Deficit	Total
Balance at Dec. 31, 2020			$ 2,060	$ (100)	$ (135)	$ 1,825
Balance (in Shares) at Dec. 31, 2020	66,431,920
Net Income (Loss)					1,211	1,211
Balance at Mar. 31, 2021			539		1,076	1,615
Balance (in Shares) at Mar. 31, 2021	81,039,900
Distributions to shareholders			(1,521)			(1,521)
Payments of subscription receivables				100		100
Exercise of Moon warrants (in Shares)	14,607,980
Balance at Dec. 31, 2021	$ 1		36,156		(49,265)	(13,108)
Balance (in Shares) at Dec. 31, 2021	145,638,212	75,379
Convertible debt conversions			2,909			2,909
Convertible debt conversions (in Shares)	72,717,883
Reclassification of equity contracts to liabilities			(314)			(314)
Professional services			240			240
Professional services (in Shares)	6,000,000
Exercise of Pre-funded warrants (in Shares)	12,361,622
Cashless exercise of warrants (in Shares)	220,754
Stock based compensation			111			111
Vesting of restricted stock (in Shares)	500,000
Net Income (Loss)					(3,033)	(3,033)
Balance at Mar. 31, 2022	$ 1		$ 39,102		$ (52,298)	$ (13,195)
Balance (in Shares) at Mar. 31, 2022	237,438,471	75,379